Revised: 2 October 2019
Information for Industry
Guidance on the regulatory processes for suppliers in New Zealand of medicines and medical devices.
Industry News
Date | Type | Title |
---|---|---|
13/5/2024 | Alert Communication | Promethazine (oral): Do not use in children under 6 years of age due to the risk of psychiatric and central nervous system side effects |
11/4/2024 | Consultation | Outcome of the consultation on standards for contraceptive devices in New Zealand |
8/4/2024 | Alert Communication | Do not use NaturaCoco Moisturising Cream or Dok Apo Moisturiser Soothing Cream |
8/4/2024 | Monitoring Communication | Calcium channel blockers and the possible risk of new-onset eczema |
20/3/2024 | Consultation | Outcome of the consultation on the proposed updates to the Guideline on the Regulation of Therapeutic Products in New Zealand: Pharmacovigilance (medsafe.govt.nz) |
If you have a query that is not answered by the information in this section please contact us at askmedsafe@health.govt.nz